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Abstract
Background: Colonic polyps are common tumors occurring in ~50% of Western populations with ~10% risk of
malignant progression. Dietary agents have been considered the primary environmental exposure to promote
colorectal cancer (CRC) development. However, the colonic mucosa is permanently in contact with the microbiota
and its metabolic products including toxins that also have the potential to trigger oncogenic transformation.
Aim: To analyze fecal DNA for microbiota composition and functional potential in African Americans with pre-
neoplastic lesions.
Materials & Methods: We analyzed the bacterial composition of stool samples from 6 healthy individuals and 6
patients with colon polyps using 16S ribosomal RNA-based phylogenetic microarray; the Human intestinal Tract Chip
(HITChip) and 16S rRNA gene barcoded 454 pyrosequencing. The functional potential was determined by sequence-
based metagenomics using 454 pyrosequencing.
Results: Fecal microbiota profiling of samples from the healthy and polyp patients using both a phylogenetic
microarraying (HITChip) and barcoded 454 pyrosequencing generated similar results. A distinction between both sets
of samples was only obtained when the analysis was performed at the sub-genus level. Most of the species leading
to the dissociation were from the Bacteroides group. The metagenomic analysis did not reveal major differences in
bacterial gene prevalence/abundances between the two groups even when the analysis and comparisons were
restricted to available Bacteroides genomes.
Conclusion: This study reveals that at the pre-neoplastic stages, there is a trend showing microbiota changes
between healthy and colon polyp patients at the sub-genus level. These differences were not reflected at the
genome/functions levels. Bacteria and associated functions within the Bacteroides group need to be further analyzed
and dissected to pinpoint potential actors in the early colon oncogenic transformation in a large sample size.
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Introduction
Colorectal cancer (CRC) is the third most prevalent cancer
[1-3]. Its world distribution is heterogeneous with a
predominance in the Western world. This heterogeneous
distribution is also taking place within the Western societies
[4,5]. African Americans (AAs) have a high incidence of, and
mortality from this disease [6,7]. Several factors have been
proposed and investigated, including genetics, epigenetics,
diet, socioeconomic status and access to health [8-15].
However, in comparison with their African counterparts, with
whom they share the same genetic background and who have
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a very low burden of the disease [16], the higher incidence in
AAs seems to be caused primarily by environmental factors.
Emerging data suggest an essential, mutualistic relationship
between the host and their colonic microbiota [17-19]. Elegant
experiments demonstrated, for example, that a single
commensal, Bacteroides thetaiotamicron induces colonic
mucosal gene expression, angiogenesis and immune
responses revealing a broader extent of microbe-mucosal
communication and cross-regulation than previously
recognized [20]. Similar findings were also obtained with an
enterotoxigenic Bacteroides fragilis [21,22].
Among body sites normally hosting a community of
microbes, the human colon harbors the greatest number and
diversity of organisms, primarily bacteria. Comprised of 500 to
1,000 bacterial species with two to four million genes, the gut
microbiome contains about 100-fold more genes than the
human genome and the estimated 1014 bacterial cells in the gut
exceed by 10-fold the total ensemble of human cells [23].
Molecular analysis of the colonic luminal and mucosal
microbiota indicates that individuals harbor unique microbiotas
that are fairly stable along the colonic axis. However, the
mucosal microbiota is either distinct or contains only a subset
of the bacterial phylotypes identified in the luminal fecal
samples [24,25]. Although mechanisms accounting for the
composition and assemblage of the gut microbiota are
incompletely understood, it appears that diet, host genetics,
disease state (e.g. obesity, Inflammatory Bowel Disease (IBD))
as well as likely additional environmental factors influence the
composition and the function of the colon microbiota [26,27].
The environmental exposures proposed to promote the
development of human CRC have been primarily dietary
agents. However, the local environment to which the colonic
mucosa is exposed is created by the microbiota of the colon
and their metabolic products that include beneficial
components such as short chain fatty acids as well as harmful
ones including toxins. Although it has been hypothesized for
decades that the colonic microbiota influence CRC
pathogenesis, neither specific bacteria nor mechanisms have
been delineated [28-30]. Linkage of specific bacteria, their
toxins and/or toxic metabolites (including mutagens) to CRC
pathogenesis has been hampered by limited knowledge of the
colonic microbiota and changing bacterial classification
schemes over the last 40 years. While two divisions of bacteria
(Bacteroidetes and Firmicutes) are considered dominant in the
cultured colonic microbiota, up to 80% of the colonic microbiota
has not yet been cultured [24,25]. Actinobacteria were also
reported as prevalent in the intestinal tract but their presence
has been underestimated in PCR based approaches [31].
Recent advances in sequencing have set the ground for
sequence-based metagenomic studies that target the genomic
diversity within an ecosystem Indeed, several studies have set
the framework for metagenomic studies in general and for the
gut microbiota in particular [24,25,32-36]. Huge databases for
16S rRNA genes as well as for gut microbiota functions have
been established as a resource for other studies in the field.
We here performed a microbiome analysis of stool samples
from healthy and colon polyp patients to elucidate bacterial
changes that might induce or accompany early oncogenic
transformation of the colon in African American patients with
the goal of defining such markers for non-invasive screening
protocols.
Materials and Methods
Ethics statement
The present study was approved by the Howard University
Institutional Review Board. Written consent forms were
obtained from all participants.
Samples collection and preparation
Fecal samples were obtained from 6 healthy (AFR001-006)
and 6 colon polyp (AFR007-012) African American individuals
who were informed about the study’s goals and consented to
participate according to Howard University IRB approved
protocol. Patients with family history of colon cancer or
inflammatory bowel diseases were excluded from this study.
We included in the study adult patients who underwent
screening colonoscopy and for whom a pathological diagnosis
was established.
Each patient was given a kit with instructions for sample
collection in sterile containers. The stool samples were
collected at least two months after colonoscopy after a full
microbiota restoration [37]. The patients were provided FedEx
enveloppes to send samples immediately after bowel
movements. The samples were delivered to us on the same
day of collection to minimize changes in the microbiota
composition. The samples were aliquoted and stored at -80°C.
Colonoscopy and pathology reports were reviewed and used to
select healthy and colon polyp patients for stool samples
collection. The healthy and polyp patients were matched for
demographic parameters to reduce the effect of cofounders on
microbiota’s differences. All polyp patients have colonic lesions
of hyperplastic histology. The Healthy group had a mean age
(SD) 59 years (9.4) and a BMI (SD) of 30.8 (4.41) while the
polyp patients mean age (SD) was 59 years (8.4) and their BMI
(SD) was 31.6 (3.56). There were 3 males and 3 females in
both groups that were age matched across the two groups of
patients.
DNA extraction
DNA from the stool samples was extracted using the
QIAamp Stool DNA extraction Kit (Qiagen, Inc). The extracted
DNA was used for 16S rRNA gene based barcoded 454
pyrosequencing and phylogenetic microarraying for microbiota
profiling using the Human Intestinal Tract Chip (HITChip) [38]
as well as for the metagenomic analysis.
HITChip analysis
DNA was used for phylogenetic profiling using the Human
Intestinal Tract Chip (HITChip), a phylogenetic microarray
which contains a duplicate set of 3,631 probes based on 16S
rRNA gene sequences covering more than 1,100 intestinal
bacterial phylotypes [38]. Briefly, 20 ng of DNA from each
sample (n=12) was used to amplify the nearly full 16S rRNA
genes. PCR products were in-vitro transcribed into RNA,
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labeled with Cy3 and Cy5 and subsequently fragmented.
Hybridizations were performed in duplicate and data were
extracted from microarray-scanned images using Agilent
Feature Extraction software version 10.7.3.1 (http://
www.agilent.com). Array normalization was performed using a
set of R-based scripts (http://r-project.org) in combination with
a custom designed relational database which runs under the
MySQL database management system (http://
www.mysql.com).
Hierarchical clustering of probe profiles was carried out by
calculating a distance matrix between the samples based on
the squared difference between each pair of profiles (Euclidian
distance). The distance matrix was used in the hclust
implementation in R of a hierarchical clustering algorithm. The
agglomeration method used in this algorithm was Ward’s
minimum variance method. The bacterial composition was
compared at the phylum level (divided into class level for the
Firmicutes) and at the genus-like level (131 phylogenetic
groups with 90% or more 16S rRNA gene sequence similarity)
using the Wilcoxon signed-rank test that was corrected for
multiple comparisons (q value), in which q<0.05 was
considered significantly different. The diversity was determined
calculated using the Shannon index of diversity on probe signal
intensities. Principle component analysis based on probe
profiles was performed using CANOCO 4.5 software package
(Biometrics, Wageningen, the Netherlands).
16S rRNA profiling by 454 pyrosequencing
DNA from each of the 12 stool samples was amplified using
primers that targeted the V1-V3 regions of the 16S rRNA gene
[39]. These primers included the A and B adaptor sequences
for 454 pyrosequencing as well as a unique 12 bp barcode
incorporated onto the reverse primer such that each sample
receives its own unique barcode. The barcode sequences for
all 12 samples are provided in File S2. This method of
incorporating the A and B adaptors onto the primers at the
PCR stage provided minimal loss of sequence data when
compared to previous methods that would ligate the A and B
adaptors to every amplicon after amplification. This method
also allows to generate sequence reads which are all in the
same 5’-3’ orientation. Using approximately 100ng of extracted
DNA, the amplicons were generated with Platinum Taq
polymerase (Invitrogen, CA) and by using the following cycling
conditions: 95°C for 5min for an initial denaturing step followed
by 95°C for 30 sec, 55°C for 30 sec, 72°C for 30 sec for a total
of 35 cycles followed by a final extension step of 72°C for 7 min
then stored at 4°C. Once the PCR for each sample was
completed, the amplicons were purified using the QIAquick
PCR purification kit (Qiagen Valencia, CA), quantified,
normalized, and then pooled in preparation for emulsion PCR
followed by 454 sequencing using Titanium chemistry (Roche,
Basel Switzerland) following the manufacturer’s protocol. In the
first step of data processing, the generated sequence data
were deconvolved using the sample barcodes to identify
sequences from each of the samples. Barcode, primer, and
adaptor sequences were also trimmed as part of this step. PCR
artifacts “chimeras” were identified using the ChimeraSlayer
program (http://microbiomeutil.sourceforge.net; reference http://
genome.cshlp.org/content/21/3/494.long), and removed prior to
downstream analysis. The resulting deconvoluted and filtered
sequence data were assigned taxonomy (to the genus level)
using the Ribosomal Database Project (RDP) classifier [40]
and the genera classifications were used to generate a sample-
genus count matrix. Operational Taxonomic Unit (OTU)
analysis of these sequences was performed as follows:
sequences were processed (trimmed) using the Mothur
software [41] and subsequently clustered at 97% sequence
identity [42] using cd-hit [43] to generate OTUs. The OTU
memberships of the sequences were used to construct a
sample-OTU count matrix. The samples were clustered at
genus and OTU levels using the sample-genus and sample-
OTU count matrices respectively. For each clustering, Morisita-
Horn dissimilarity was used to compute a sample distance
matrix from the initial count matrix, and the distance matrix was
subsequently used to generate a hierarchical clustering using
Ward’s minimum variance method. The Wilcoxon Rank Sum
test was used to identify OTUs that had differential abundance
in the healthy and polyp sample groups.
Metagenomic analysis
Prepared DNA from the 12 stool samples was processed
using the Genomiphi MDA kit (GE-Healthcare) using the
manufacturer’s suggested protocol, in preparation for library
construction for 454 sequencing.  The sample preparation
process in this system involves fragmentation of MDA amplified
genomic DNA, followed by ligation of MID barcodes and 454
adaptor sequences.   Each sample was then normalized,
pooled then loaded into a half picoliter plate for 454
sequencing.  The samples were then amplified using emulsion
PCR followed by 454 sequencing using Titanium chemistry.
The metagenomic sequence data were first processed to
remove 454 artifacts (replicate reads arising from the emulsion
PCR process) [44] and then genes were identified on reads
using a frameshift tolerant gene finder (FragGeneScan) [45] so
as to overcome any 454 homopolymer problems. These genes
were then searched against the KEGG database to identify
kegg ortholog counts [46,47].
All of the 16S and metagenomic data generated in this study
have been deposited in the NCBI's Sequence Read Archive
(http://www.ncbi.nlm.nih.gov/bioproject/222611).
Results
HITChip based taxonomy analysis
The HITChip analysis revealed the bacterial profile within
each of the analyzed samples as well as the clustering of these
samples based on profiles’ similarities/dissimilarities. The
clustering based on the generated profiles did not reveal a
clear separation between the polyp and healthy samples’
profiles. The samples in the generated clustering were
intermixed with 3 polyp (AFR011, 010 & 007) and 3 healthy
samples (AFR005, 001 & 006) on one side of the dendrogram
located distantly from the other polyp (AFR008, 009 & 012) and
healthy samples (AFR002, 003 & 004) (Figure 1).
Bacteroidetes and Firmicutes were prevalent in all samples
and totaling about 92% of the total detected bacteria. Another
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important group was Proteobacteria which was represented by
~7% of the probes in both sets of samples. Healthy individuals
had a relatively higher prevalence of Bacteroides (37.4 vs.
34.7%) while polyp samples had a higher prevalence of
Firmicutes (56.2 vs. 54.6%). The prevalence of Proteobacteria
was 6.4 and 7.4 in healthy and polyp samples, respectively
(Figure 2). At the genus level, there were several bacteria that
displayed relative abundances in the analyzed sets of samples
as depicted in Figure 3 and associated File S1.
454 pyrosequencing taxonomic analysis
In parallel to the HIT Chip analysis, we analyzed the same
sets of samples using 454 pyrosequencing where V1-V3
variable region of the 16S rDNA sequence was PCR amplified
and sequenced. The generated sequences were analyzed
using the Ribosomal Database project data and sequence
identification was established (File S2). Bacteroides and
Firmicutes represented 80 to 85% of the sequences in both
sets of samples with a higher prevalence of Bacteroides in
healthy samples vs polyps and a higher prevalence of
Firmicutes in polyp samples vs. healthy ones. Proteobacteria
Figure 1.  Dendrogram of the samples’ clustering based on the global HITChip oligonucleotide probe signal intensities
(AFR001-006; Healthy patients’ samples, AFR007-012: Polyp patients’ samples).  
doi: 10.1371/journal.pone.0081352.g001
Figure 2.  Barplots showing the relative abundances of bacterial phyla in healthy and colon polyps patients’ samples
determined by HITChip profiling.  
doi: 10.1371/journal.pone.0081352.g002
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were the third major group of bacteria accounting for ~10% of
the sequences (Figure 4). A clustering of the samples based on
the generated sequences at the genus level led to the
dendrogram depicted in Figure 5, in which the healthy and
polyp samples were intermixed. Polyp samples AFR011, 010 &
007 clustered with healthy samples AFR002 & 006 while polyp
samples AFR008, 009 & 012 clustered with healthy samples
AFR001, 003, 004 and 005 (Figure 5).
Further clustering at the Operational Taxonomic Units level
(OTU: sub-genus level) led to a different repartition of the
analyzed samples (Figure 6). In this figure, a better resolution
was obtained with polyp samples AFR008, 010, 011 & 012
clustering together with healthy sample AFR003 while polyp
Figure 3.  Barplots showing the relative abundances of bacterial groups at genus-like level in healthy and colon polyps
patients’ samples determined by HITChip profiling.  Bacterial groups that are at least 1% in one of the samples are shown.
doi: 10.1371/journal.pone.0081352.g003
Figure 4.  Bacterial phyla and genera distribution in healthy (Blue) and colon polyps (Red) patients’ samples based on
454 pyrosequencing data.  
doi: 10.1371/journal.pone.0081352.g004
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samples 006 and 007 clustered with the other healthy samples
(Figure 6). More importantly, the height (branching distance)
obtained at the sub-genus comparison (Figure 6) was bigger
than that obtained in the genus level comparison (Figure 5)
pointing to much more differences between the two groups at
the OTU rather than the genus level. Seven out of 11 OTUs
that led to this separation consisted of Bacteroides (Table 1).
Metagenomic analysis
The raw count for Kegg Orthologs (KOs) were used to
calculate the proportion of KOs in each of the twelve
metagenomic datasets (Files S2, S3 & S4) using a method that
accounts for difference in gene lengths [46,47]. These
proportions were used in a Wilcoxon Rank Sum test to identify
kegg orthologs that were differentially abundant in the healthy
and disease sample groups. Overall, after correcting for
multiple testing, we did not see statistically significant groups
(Kegg Orthologs) using a false discovery rate of 5%. Because
most of the OTUs leading to a higher resolution of the analyzed
samples were from the Bacteroides group, we performed an
analysis of the metagenomic data against available
Bacteroides genomes (File S5). All reads from each sample
were searched against available Bacteroides genomes. A read
was considered as mapping to a genome if its match to the
genome had ≥80% identity and covered ≥80% of the read
sequence. Overall, the healthy samples have a slightly higher
mean proportion of recruitment to Bacteroides, though this
seems to be driven primarily by sample AFR005. The IDs of all
Bacteroides genome sequences used in this analysis are
included in File S5.
Discussion
The microbiota have long been overlooked and nowadays
there is an increasing interest in studies that seek to define
their role in health and disease [48-50]. The most important site
for these studies is the gut since the intestinal microbiota plays
major roles in nutrition, metabolism and immunity [48-50]. It
has been well documented that many intestinal diseases have
bacterial components such as in the case of ulcerative colitis
and Crohn’s disease [51]. Their role in triggering or promoting
colon oncogenic transformation has yet to be established even
though many publications reported the potential of many
individual bacteria to induce tumorigenesis in germ free mice
[21,22].
Figure 5.  Dendrogram reflecting the healthy (AFR001-006) and colon polyps (AFR007-012) samples clustering based on
the 454 pyrosequencing data analyzed at the genus level.  
doi: 10.1371/journal.pone.0081352.g005
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Here we report experiments where we show that there is a
trend of specific bacterial profiles in colon polyp patients when
compared to healthy individuals. We used two technologies to
investigate the microbiota’s profiles in our sets of samples.
Both the phylogenetic microarraying using the HITChip and
454 pyrosequencing generated similar results and similar
bacterial groups distribution. Similar findings were reported by
Van den Bogert et al. who reported comparable results from
stool and small intestinal samples when the two technologies
were compared even when different sets of 16S rRNA primers
were used [52].
The genus based clustering using data from both
technologies was similar which reflects the strength of both
technologies in microbiota profiling. However, no clear
resolution of the two sets of samples was obtained at the
genus level. Further analysis at the sub-genus level, led to
much clearer separation of the samples with 4 of the polyp
patients bacterial profiles clustering on one side of the
generated dendrogram with bigger branching distance
separating the two clusters in the sub-genus dendrogram
(Figures 5 & 6). This finding is to be expected since changes in
the microbiota in the oncogenic transformation are thought to
Figure 6.  Dendrogram reflecting the healthy (AFR001-006) and colon polyps (AFR007-012) samples clustering based on
the 454 pyrosequencing data analyzed at the Operational Taxonomic Unit (OTU: sub-genus) level.  
doi: 10.1371/journal.pone.0081352.g006
Table 1. Differential OTUs leading to the separate clustering of the healthy and colon polyps samples the sub-genus level
data analysis.
•OTU p-value Taxonomy      
•OTU_1776 0.002165 Bacteria Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides
•OTU_1807 0.002165 Bacteria Firmicutes Clostridia Clostridiales Lachnospiraceae  
•OTU_96 0.016059 Bacteria Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides
•OTU_1775 0.016711 Bacteria Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides
•OTU_338 0.028441 Bacteria Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides
•OTU_485 0.030348 Bacteria Firmicutes Clostridia Clostridiales Lachnospiraceae  
•OTU_1312 0.037941 Bacteria Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides
•OTU_224 0.037941 Bacteria Firmicutes Clostridia Clostridiales   
•OTU_1127 0.040253 Bacteria Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Coprobacillus
•OTU_1554 0.041596 Bacteria Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides
OTU_177 0.043826 Bacteria Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroide
doi: 10.1371/journal.pone.0081352.t001
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be taking place within the existing microbiota where previously
less represented bacterial strains become dominant or
unexpressed bacterial functions become induced in response
to some environmental stressors [53,54]. Diet is known to be
an important effector of both microbiota composition and
colorectal cancer risk. The magnitude and nature of its effects
can only be assessed in well controlled prospective studies.
Bacteroidetes and Firmicutes were the most prevalent
groups of bacteria detected in all samples. Proteobacteria
corresponded to the next group of relevance in our samples.
The sub-genus bacteria that led to the new clustering were
predominantly from the Bacteroides group in the polyp patients’
samples (7 out of 11). Yoshino et al. have reported that
Bacteroides bacteremia as strongly associated with colorectal
cancer in Japanese patients [55]. Also, Wu et al. have shown
that strains from the Bacteroides fragilis species carrying the
bft gene (toxin) are able to promote colon oncogenic
transformation in mice models of colon cancer through pSTAT3
pathway [21,22]. Also, Toprak et al. did report a 38%
prevalence of bft in colon cancer stool samples vs. 12% in
control patients [56].
In an immunohistochemistry experiment using a pSTAT3
antibody on tissue microarray using both African American
normal and adenoma tissue samples, adenoma samples were
strongly stained when compared to normal samples (data not
shown). pSTAT3 is the preferential pathway induced by bft
toxin and other bacterial antigens [57]. While other bacterial
toxins, from Bacteroides bacteria or others, might trigger the
pSTAT3 pathway as well, our results do still point to the need
to further dissect such functions in Bacteroides strains.
The metagenomic analysis in our study was more descriptive
of the potential of the microbiome in African American
microbiota but did not reveal any statistically significant
markers or functions when the samples were compared either
individually or as two groups. Overall, the usual bacterial
functions were detected in the analyzed samples (See Files
S2, S3 & S4). A second analysis of the metagenomic data was
done in comparison to all known Bacteroides genomes (n=90).
This analysis did not lead to significant differences between the
two sets of samples as well.
It is noteworthy that recent publications have reported the
prevalence of Fusbacterium spp and Fusobacterium nucleatus
[58-60] in colon cancer tumors when compared to normal colon
samples. Such was not the case in the analyzed stool samples.
This finding points probably to the importance of analyzing and
establishing bacterial markers of colon oncogenic
transformation in colon tissues and subsequent validation in
stool samples. Indeed, adherent bacteria might be more prone
to affect gene expression in colon mucosal cells than transient
bacteria that are flushed in the fecal samples. Large studies of
stool and colon tissue samples from different stages of colon
cancer development are needed to establish strong bacterial
markers of oncogenic transformation.
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